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 FRO?^^ November 24, 1962 to March 30, 
1964, 64 uremic patients were treated with 
renal homografts obtained from living vol- 
unteer donors other than identical twins. 
Thirty-seven of the original group lived 
for at least 1 year and 36 are still alive 13% 
to 30 months after operation. Numerous 
post-transplant function studies have been 
obtained, and in the 8 patients with the 
longest follow up, homograft biopsies were 
performed from 21 to 24 months postopera- 
tively. The recipients who are still alive 
were esamined with a lymphocyte cyto- 
toxicity test for the degree of antigenic 
matching with their respective donors to 
determine by retrospective analysis whether 
this method might be helpful in evaluating 
the results as well as in the selection of 
donors for future cases. 
Methods 
The surgical and postoperative technics 
employed have been documented else- 
" Presented before the American Surgical As- 
sociation, Slay 12-14, 1965, Philadelphia, Pa. 
"" Slarkle Scholar. 
Aided b y  Grants AM 06283, AM 06344, HE 
07735, AM 07772, A1 04152, FR 00051, AM 
02375, A1 04444, and AM 7513 from the United 
States Public Health Service; and b y  a grant from 
the hledical Research Council o f  Great Britain. 
where 57 and were based upon the pioneer- 
ing methods developed in animals and man 
by Calne,4-6 Dempster and Shackman,12, 13* 
j2 G ~ o d w i n , ~ ~ - ~ ~  H a m b ~ r g e r , ~ ~ - ~ ~  H ~ m e , ~ ~ -  
30 ~i+~,33-36 Murray, Merrill and Harri- 
 SO^,^^-^^ Simonsen 54 and Woodruff Bg and 
their associates. Azathioprine f was used 
for immunosuppression in every case, and 
prednisone in all but two. Actinomycin C 
and local homograft irradiation " were em- 
ployed irregularly. One patient received 
400 r total body iradiation. In 6 instances 
there was immediate or very early failure 
of the initial homograft. In these cases a 
second kidney was provided 6 to 47 days 
after the original operation (Table 1 ), and 
for statistical comparisons only the second 
or definitive donor is considered. All 64 
patients had splenectomy before or at the 
time of homotransplantation. Bilateral ne- 
phrectomy was performed in .all but three. 
Seventeen patients had thymectomy, 8 be- 
fore and 9 from 250 to 520 days after trans- 
plantation. 
The causes of mortality in this series dur- 
ing the first postoperative year,57, 58, 60 as 
well as the pathologic changes in the homo- 
grafts from these unsuccessfully treated pa- 
f Imuran@ supplied b y  Burroughs Wellcome 
& Co., Tuckahoe, New York. 
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tients 2 L 7 s  49 ,58 have been described. In this 
report, attention will be confined to the 
subsequent mortality and to the histologic 
alterations in the homografts after residence 
in the host for 1 year or longer. In 8 cases, 
specimens for light and electron microscopy 
were obtained with a large open wedge 
biopsy from 21 to 24 months postopera- 
tively, and in a ninth patient tissues became 
available from an autopsy at 13% months. 
Material for examination by light micros- 
copy was fixed in formalin and Carnoy's 
solution. The biopsy specirnens were then 
completely serially sectioned. The stains 
used routinely were: hematoxylin and eosin, 
periodic acicl Schiff reagent, Weigert's for 
elastic tissue (counterstained with hema- 
toxylin and van Gieson), picro-Mallory 5, 
Martius scarlet blue, Mallory's phospho- 
tungstic acid hematoxylin (PTAH) and 
methyl green pyronin. Other special stains 
were used when indicated. Fragments of 
kidney obtained at biopsy For examination 
by electron microscopy were fixed in 
Palade's buffered osmium tetroxide solution 
and embedded in an epoxy resin.f f Thin 
sections, stained with phosphotungstic acid 
or lead, were examined with a Siemen's 
Elmiskop I electron microscope. 
The blood urea nitrogen ( B U N )  and 
creatinine clearance (CCr) were the most 
valuable routine measures of renal func- 
tion. In 12 patients, inulin and para-amino- 
hippurate (PAH) clearances were deter- 
mined in triplicate in a fasting steady state 
by the methods of Schreiner and Smith,55 
respectively. The ability of the homograft 
to concentrate and dilute urine was meas- 
ured after a complete 14-hour overnight 
fast arid a subsequent oral waterload (20 
ml./Kg.); urine osmolality was measured 
by a standard cryoscopic technic. 
The lymphocyte antigens of the surviving 
patients and their donors were analyzed 
from blood specimens shipped to Los An- 
- - -- 
f f  Araldite M@ supplied by Ciba (A.R.L.) 
Ltd., Duxford, Cambridge, England. 
geles, employing a modification of a previ- 
ously described technico4? 65 by which the 
lymphocytes are isolated by differential 
adherence of granulocytes on small glass 
beads and by lysis of erythrocytes with 
hypotonic balanced salt solutions. The 
lymphocytes of each individual were then 
reacted with a panel of 65 to 135 different 
antisera, using rabbit complement. The 
cytotoxic antisera * were obtained from 
blood donors who had been accidentally or 
deliberately sensitized to white blood cell 
antigens: women with multiple abortions 
or pregnancies, patients who had received 
multiple blood transfusions or volunteers 
who were deliberately immunized with 
either skin homografts or lymphocytes. The 
maximum potential reactivity (weight) of 
all the antisera had been defined on a unit 
basis by preliminary standardization. Using 
phase contrast microscopy the lymphocyto- 
toxic properties of the antisera were de- 
termined at various dilutions, beginning 
with 0.003 ml. serum in the first droplet 
and proceeding with 1 : 3 dilutions there- 
after. A serum which completely destroyed 
all test cells at the first dilution and none 
at the second was defined as having a one 
unit weight; destruction of all cells in the 
first dilution and 50 per cent in the second 
would imply a 1.5 unit weight. A 6 unit 
weight meant that the possibility of com- 
plete cytotoxicity was present through 6 
dilutions. The weights of the antisera used 
ranged from 1 to 6 units. 
Application of this technic to the study 
of the 36 surviving patients and their donors 
allowed both a qualitative and quantita- 
tive evaluation of their antigen differences 
(Table 2) .  When both members of a pair 
reacted the same to an antiserum, or if 
antigens not represented in the donor were 
demonstrable in the recipient, a mismatch 
- - 
* The following people donated sera to the 
antiserum panel: Drs. Ruggero Ceppellini, Jean 
Dausset, Rose Payne, Jon J. Van Rood and Roy 
Walford. 
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TAIIT.E 2. Mis~natclted C~totoxic i tv  R~ac t ions  of D:>i~or-Recipient I'air L D  25" 
Antiserum no. 20 21 24 46 50 58 64 68 81 94 101 106 122 128 154 155 
Antiserum wt. 3 2 4 2 2 4 6 4 3 5 4  5 6 3 5 6 
Cytotoxicityunitp-donor 2.3 0.9 1.6 0.3 1.5 2.9 4.0 3.0 0.6 1.4 2.0 2.6 6.0 1.6 4.3 5.3 
Cytotoxicity units-LD 25 1.9 0 0 0 0 1.7 3.0 2.9 0 O 1.9 2.0 5.9 0.9 3.6 1.3 
Units mismatch-complete 0.9 1.6 0.3 1.5 0.6 1.4 
Units misrnatch-partial 0.4 1.2 1.0 0.1 0.1 0.6 0.1 0.7 0.7 4.0 
* A  total of 106 antisera were in the panel used. Only those antisera are shown which demonstrated incoml~atibility of thr  donor 
with the recipient. S o t e  the distinction between-complete and partial mismatches. See text for terminology. 
was not considered to be present. Antigens Results 
present in the donor but not in the recipient 
~~~~~~l observations 
were considered to be Mortality During First Year. Twenty- 
matches, the magnitude of antigen reac- three of 27 deaths in the first year were 
tivity being defined by the units described within 120 days after operation, three more 
above. 1f strong antigens were measurable were in the ellsuing 4 months, and only one 
in the donor lymphocytes and similar weak patient died in the final third of the first 
ones in the recipient cells, these were Year (Table 3 ) .  The causes of failure and 
termed partial mismatches and also quan- 
titated by their reactivity with the standard 
antisera. Thus, for every case it was pos- 
sible, within the limits of the testing panel, 
to delineate the individual complete and 
partial antigen differences (Tables 2, 12), 
to estimate roughly the magnitude of these 
differences relative to the maximum pos- 
sible disparity and to obtain a total picture 
of the measured dissimilarities which might 
be predicted to evoke a recipient antibody 
response. Several methods of expressing 
the degree of incompatibility were em- 
ployed, utilizing the IBM 7094 computer."" 
- - - 
O D  Doctor XI.  R. Mickey, Jr. and Mr. Donald 
Goyette assisted in devising the programming for 
this analysis. 
' l ' a r : ~ ~  3. T i m e  of Jfortality after Nomotrans- 
plantation to 63 Patients 
Mean Survival 
Range 
Xo. (da.) (da.) 
Dead 1st 4 mo. 23 51.7 1-1 13 
Dead 2nd 4 mo. 3 188 155-207 
Dead 3rd 4 mo. 1 295 295 
Dead after 1 1-r. 1 405 405 
the pathologic findings in all these cases 
have been r ep~r t ed .~"  5 8  
Mortality and Survival After 1 Year. 
Only one of the remaining 37 homograft 
recipients died after 1 year (Table 3 ) ;  the 
other 36 are alive from 411 to 900 days 
after homotransplantation (Table 4 ) ,  with 
a mean survival of 19 months. For each 
patient still living, the number of days of 
survival after receipt of their ddnitive 
homograft is listed in Table 1. Since no 
patient has had a late second homograft, 
these data are identical with those of 
homotransplant function. Four patients are 
into their third year, 16 are 1.5 to 2 years, 
and 16 more have lived for 13.5 to 18 
months. 
TAI~LE 4. Mortality and Sz~uvisal in 64 Consecz~ti.ilc Pa- 
tients IVho Receiaed Renal HonzogvaJts front Volz~nteer 
Living Donors 13$ Months or Longer Ago 
Total no. patients 64 (100%) 
Died within 1st year 27 (42.2y0) 
Survived at  least 1 year 37 (57.8y0) 
Died after 1 year 1 (1.56%) 
Survived to date (12 May 1965)* 36 (56.25y0) 
* Mean survival of the 36 patients still alive is1576 
days. 
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TABLE 5. Effect ~,f Genetic Relationship of Donor U p o n  TABLE 7. Relation of Original Renal Disease to I-year 
1-year Suruival* Sz~vvival 
-- 
Related S o .  Survival 1 Year No. Donors Alive 1 Year 
Unrelated donor 
All related donors 
Parental 
Sibling 
Aunt, uncle or cousin 
*When two homografts were required, only the 
second 01- definitive donor is recorded. The difference 
in result's between the related and unrelated groups 
is significant (P < 0.01). 
** One of these patients died after 133 months. 
Cause of Death After 1 Year. A 48- 
year-old man, who originally had poly- 
cystic kidney disease ( L D  23, Table l ) ,  
died 405 days after homotransplantation 
from a nonrelated donor. Despite a mild 
early rejection episode, there was excellent 
renal filnction until a more severe attempt 
at homograft repudliation after 223 days, 
which was apparently precipitated by dis- 
continuance of prednis~ne. '~ The late re- 
jection was reversed by resumption of 
steroid therapy, local homograft irradiation 
TABLE 6. In juence  qf Donor and Recipient Blood Types  
7ipon 1- Year Survkal*  
No. Ileaths 
1 Yr. in 1st 
Blood T y l ~ e  No. Surv. Year 
Glomerulonephritis 49 37 32 (65.3%) 
Pyelonephritis 10 6 3 (307,) 
Polycystic kidney disease 3 1 2* (66.7%) 
Congenital renal hypoplasia 1 1 0 (0%) 
Surgical removal of sole kidney 1 1 0 (0%) 
*One of these patients died after 13f months. See text. 
and administration of 400 pg. actinomycin 
C every 5 to 14 days. The depressed CCr 
and elevated BUN returned to 55 to 85 
ml./min. and 25 to 40 mg./100 ml., respec- 
tively, despite which hypertension per- 
sisted. A renal arteriogram in June 1964 (by 
Dr. John Bergan of Chicago) showed 
patency of the major vessels but a gen- 
erally reduced diameter of the peripheral 
branches (Fig. 1, left). The patient worked 
daily until September 1964 when he de- 
veloped progressive jaundice. Although the 
azathioprine dose was halved and later dis- 
continued (by Dr. C. Larkin Flanagan of 
Chicago), he became leukopenic, devel- 
oped a gram-negative septicemia and died 
on October 4, 1964. 
At autopsy (performed by Dr. G. A. 
Lorenzo, Chicago Wesley Memorial Hos- 
pital), he was found to have bilateral 
bronchopneumonia and a retroperitoneal 
abscess in the old left nephrectomy bed 
Type o recipient ~18 th  : from which the same organisms were cul- 
Related 0 donor 20 15 (75%) 5 
Unrelated o donor 7 3* (43%) 4 tured as were in the blood stream. The 
Related A donor 
Type A relzipient w ~ t h :  
Related A donor 
Unrelated A donor 
Related 0 donor 
Unre1atf.d 0 donor 
Related B donor 
Type B recipient with: 
Related B donor 
Unrelated B donor 
Unrelated 0 donor 
Type AB recipient with: 
IJnrelated AB donor 
tinrelatrd A donor 
Total 
*For  the 6 patients who received a second homograft, be- 
cause of immediate or early failure of the first transplant, only 
the second or definitive donor is tabulated. 
**One of these patients subsequently died after 405 post- 
transplant days. 
liver weighed 2,500 Gm. Microscopically 
there was acute liver necrosis involving 
primarily the centrilobular area and fat ac- 
TABLE 8. Effect of Age on 1-year Survival 
No. Non- 
No. 1-year related 
Age Patients Survivals Donors 
0-10 4 2 0 
11-20 15 12 2 
21-34 20 12 3 
35-44 17 8 8 
45-55 8 3 5 
- 
Total 64 37 18 
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TABLE 9. Incidence and Effect of Late Rejection (after 3 i'fonths) in 64 Patients o j  LD Series 
Days 
Days After Permanent 
Patient After Steroid Alive or Dead Functional 
(LD No.) Oper. Change* (May 1965) Damage 
Died of rejection 
a t  295 da. 
Alive at  705 da. 
Alive a t  679 da. 
Alive at  639 da. 
Died of hepatitis & 
septicemia a t  405 da. 
Alive a t  590 da. 
Alive at  536 da. 
Alive at  494 da. 
Alive a t  488 da. 
Yes 
Yes 
No 
No 
Yes 
Yes 
Yes 
Yes 
Yes 
* In 5 of the 8 cases prednisone had been stopped. For LD 30, the dose had been reduced from 45 to 30 mg/ day. 
For T,1> 11,47 and 48, doses had been dropped from 5,20 and 20 mg to 2.5, 15 and 15 mg/day, respectively. 
cumulation in .the remaining hepatocytes. 
In addition there was reticulin condensa- 
tion and chronic fibrosis which was con- 
centrated around and often interconnected 
the portal tracts. Lymphocytes, plasma 
cells, macrophages and occasional neutro- 
philes were in the portal areas. 
Influence of Donor Genetic Relation- 
ship upon Mortality. More than two thirds 
of all patients treated with homografts 
from related donors are still alive (Table 
5 ) .  With parent to offspring transfers, the 
survival after 13% to 30 months is 70 per 
cent, slightly but not significantly greater 
than that with sibling donations (60%).  
Three patients who received a kidney from 
an aunt, uncle or cousin are also well. 
The results after homotransplantation 
from unrelated donors are less favorable 
(Table 5).  Six of 18 patients in this group 
lived for at least a year, but one subse- 
quently died. The other five have stable 
homograft function 617, 590, 576, 443 and 
411 days post-transplantation (mean 527 
days). 
TABLE 10. Renal Fzmction Tests-Adult Patients With Related Donors 
% of 
Survival UOam Water 
@ Time (mOsm./L.) Load Ex- 
of Study GFR* ERPF** creted in 
LD # (&lo., (ml./min.) (ml./min.) F.F.1- Min. Max. 3 Hours 
* Measured as inulin clearance. 
** Measured as PAH clearance. 
1. Filtration fraction (Cin/Cp~n X 100). 
1.t Had a previous late rejection. Note that these patients have the poorest function. 
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TABLE 11. Renul Fzhnctinn Tesls-Adult Patients With Unrelated Donors 
% of 
Survival Uoem LVater 
@ Time (mOsm./L.) Load Ex- 
of Study GFR* ERPF** - creted in 
LI) # (Mo.) (ml./min.) (ml./min.) F.F.1 Min. Max. 3 Hours 
Mean 16.1 60.2 268 22.5 188 600 40.3 
* Measured as inulin clearance. 
** Measured as PAH clearance. 
t Filtration fraction ( C ~ ~ / C P A H  X 100). 
tt Had a previous late rejection. 
Influence of Blood Types upon Results. report it was observed that recipients of A 
The blood types of the donors and re- blood group who received kidneys from A- 
cipients in each case are given in Table 1 type donors had a high ultimate failure 
and sun~marized in Table 6. In an earlier rate compared to patients with 0, A and B 
FIG. 1. Arteriograms of renal homografts. (Le f t )  Patient L D  23, 10 months after homotransplanta- 
tion. Arrow indicates end-to-side renal artery-iliac artery anastomosis. Note reduced caliber of the 
intrarenal vessels. Patient had suffered a late rejection several months earlier and had become hyperten- 
sive. He died from nonrenal causes 4 months after this x-ray ancl histologic studies of the homograft 
showed severe obliterative arterial lesions. (Right) Patient L D  1, 2 years after operation. Blood pressure 
was 100/70. Vascularity of the transplant seems normal. Despite this, biopsy on the same day revealed 
obliterative lesions of smaller vessels (Fig.  9, 12) .  Excellent function was present before and in the 6 
months after examination. Note iatrogenic dissection of contralateral common and external iliac arteries 
by  the catheter for which excision and prosthetic replacement of the entire iliac system was necessary. 
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TABLE 12. Strri~tnary of Cytotoxicily Reactions i n  36 Long-Term Donor-Recipient Pairsi- 
Total Total 
No. Sera No. Sera % Sera Total 
c E c Complete Total Weight % Total 
Patient Complete Complete Complete Units Units of Units Units 
(1.D No.) Mismatches Matches Mismatches Mismatch Mismatch Tested Mismatch 
Related 
Unrelated 
8 69 10.4 9.4 14.5 252 
8 112 6.7 11.9 23.4 365 
13 9 1 12.5 16.2 38.1 348 
17 92 15.6 28.5 46.5 326 
23 78 22.8 38.6 44.1 307 
t C:ises are listed in order of decreasing antigen compatibility. 
* Indicates "superior" result. 
I'alients not designated with an asteric, have "satisfactory" result. 
*" Indicates "less than satisfactory" result. 
type 117110 were treated with homografts fluence the outcome providing the incom- 
from type 0 donors.60 With more cases and patibilities described below are avoided. 
a longer follow up these findings persist, It  is now recognized 2g, 57 that tissue 
but the difference in results has consider- transfer bewteen donors and recipients of 
ably lessened (Table 6 ) .  At the moment it different blood types should conform to the 
seems improbable that blood types in- general rules which apply for nonmatched 
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'- POST-TRANSPLANT- MONTHS 
FIG. 2. Course of Patient LI) 2 who received a hoinograft from his sister 27% months ago. He was 
AS blood type; hers was BS. Thymectomy was performed 2 weeks before transplantation. A severe re- 
jection with anuria developed 25 days postoperatively, but this was totally reversible. Steroids were 
discontinued by the ninth month. A homograft biopsy at 2 years was completely normal both by light 
and electron microscopy. 
blood transfusions. Early in our experience 
this scl~eme was violated in four cases. 
Two homografts of A and B type failed 
immediately in type 0 recipients, appar- 
ently due to binding of host isoagglutinins 
to the red cell antigens which are known 
to be present in renal tissue.ls, 27 ,  0 2  In a 
third case (A to O) ,  the homograft func- 
tioned well for 202 days until the re- 
cipient's death from nonrenal causes ( L D  
20, Table 1). A fourth patient ( L D  2 )  of 
A blood group who received a kidney from 
his B-type sister is in good health 832 days 
after operation with excellent renal func- 
tion (Fig. 2).  Thus the principal risk with 
the use of the unacceptable donor-re- 
cipient blood type incompatibilities seems 
to be an acute one which is based upon 
an immunologic reaction that may be quite 
distinct from that of rejection. Although 
such tissue combinations should not be 
used in the future because of the danger 
of immediate failure, it is pertinent in con- 
sidering the role of red cell antigens in re- 
jection that long-term function has been 
obtained in the above two cases. 
Influence of Original Disease upon 1- 
Year Survival. Thirty-two of the 49 pa- 
tients with chronic glomerulonephritis lived 
1 year or more (Table 7 ) .  Three of ten 
patients with end-stage pyelonephritis sur- 
vived for 1 year; these three all received 
homografts from related donors. Two of 
three patients with polycystic kidney dis- 
ease lived for at least 12 months. The data 
are too small to do more than indicate 
that chronic survival is possible after homo- 
transplantation for the treatment of various 
renal diseases. 
Effect of Age upon 1-Year Survival. 
Twenty-six of 39 patients who were 34 
years or younger (66.7%) lived for 12 or 
more months (Table 8 ) .  Only 11 of the 25 
patients who were 35 or older (44%) had 
a comparable survival. The poor results in 
the older age groups were at  least partially 
due to the higher number of nonrelated 
donors, but there was also an increased 
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FIG. 3. Course of Patient LD 1 who received a homograft from his mother almost 30 months ago. 
Donor and recipient were both BS blood type. Thymectomy was performed 30 days before transplanta- 
tion. Total body irradiation was given before (300 r )  and after (100 r )  insertion of the homograft. 
An early, reversible rejection was followed by stable function except for a transient decline following re- 
pair of an iatrogenic dissecting iliac artery aneurysm (Fig. 1 right). Despite doubling of weight, the daily 
dose of azathioprine has remained constant. Steroids were discontinued 9 months postoperatively. Note 
the prompt leukocytic response to upper respiratory infections (URI) and surgical trauma. The second 
URI was accompanied by a herpes simplex which healed without incident. Sections of this patient's 
homograft after 2 years are illustrated in Fig. 9, 12-17. 
incidence of complications from other organ 
Chronic Immunosuppressive Therapy. 
All the chronic survivors are being treated 
with azathioprine, and the majority with 
prednisone as well. In most patients the 
dose of azathioprine per kilogram declined 
late after operation: first, because the ac- 
tual daily amount was ultimately reduced 
to slightly less than that employed during 
the critical early period of recovery; and, 
second, because the dose was frequently 
held stable despite a substantial weight 
gain which usually followed successful 
transplantation. The influence of both fac- 
tors is evident in Figure 3. Another example 
is in an adult patient (Fig. 4 )  who has had 
a slowly diminishing dose, despite a weight 
gain of 126 to 148 pounds. Late bone mar- 
row depression has been observed only in 
the patient described earlier who died 
after 405 days. 
In two cases (LD 15 & 36) the azathio- 
prine dose was attenuated even more 
drastically following the development of 
jaundice within the first year after opera- 
tion. Because of the known hepatotoxicity 
of azathioprine g, 69 the dose was reduced' 
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FIG. 4. Course of Patient LD 6 who received a homograft from his younger brother on April 17, 
1963. Both were O+ blood type. Renal biopsy after 2235 months was essentially normal. The patient 
had a pretransplant thymectomy. Steroid therapy was stopped after 5 months. Note that the total 
azathioprine close has been slowly reduced despite an increase in body weight from 126 to 148 pounds. 
to 0.63 mg./Kg./day in one patient (Fig. practice led to late rejection episodes in 9 
5) and 1.7 mg./Kg./day in the other. Re- cases. 
sults of liver-chemistry studies improved Late Rejection. The characteristics of 
in both without deterioration of renal func- delayed rejection (after 3 months) were 
tion in either. described in an earlier report " based upon 
Results with prednisone have been more observations in 6 cases. I t  was pointed out 
variable. Two patients (LD 3 & 14) never that the complication seemed to have been 
had a rejection and have received only related in each instance to reduction (Fig. 
azathioprine. Prednisone was administered 6 )  or discontinuance (Fig. 7 )  of the pre- 
to the other 62, beginning either at the existing prednisone dose. Three additional 
time of transplantation or within the first examples have subsequently been encoun- 
few weeks thereafter; in all an effort was tered under similar circu~nstances, bring- 
made subsequently to reduce the dose. ing the total to 9 (Table 9 ) .  
In six patients it has been possible to dis- Late rejection occurred 112 to 390 days 
continue prednisone with continuing stable after transplantation, and in all but one 
renal function for the ensuing 3 to 21 patient it was controlled by resumption 
months (Fig. 2-4). The maintenance doses of or increased doses of prednisone with 
for the others are 15 mg./day or less with actinomycin C or local homograft irradia- 
a few exceptions. The present steroid ther- tion or both. Six of eight patients in whom 
apy for each of the 36 surviving patients is it was possible to reverse the process 
individually recorded in Table 1. I t  is prob- had measurable residual reduction of renal 
able that others could have prednisone function, and in one the degree of long- 
stopped without harmful effect. There has term impairment has been relatively severe 
been a reluctance to test the possibility be- (Fig, 6 ) .  The present BUN, CCr and blood 
cause of the evidence cited below that this pressure for the surviving patients listed in 
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FIG. 5. Drastic reduction of inlmunosuppression in a patient who became jaundiced after transplanta- 
tion. Note the development of hyperbilirubinemia while the patient was receiving large quantities of 
azathioprine, and its remission as the dose was reduced. His weight has steadily increased as both 
steroids and azathioprine have been withdrawn. Detailed function studies after 21 months were normal 
despite a few abnormalities in the renal biopsy performed at this time. The homograft was provided 
by the patient's brother. The recipient was A+ blood type; the donor was O+. Late th mectomy was 
performed because of the necessity for attenuation of imnlunosuppression; the value o f  this adjuvant 
procedure is unproved. 
Table 9 are recorded under the same L D  
numbers in Table 1. I t  is probable that 
these patients will require steroid therapy 
for the rest of their lives. 
Late Urologic Complications. Four pa- 
tients required late reconstructive opera- 
tions 58 for ureteric strictures either a t  the 
site of the ureterovesical anastomosis or 
proximal to this. All four (LD 27, 39, 44, 
50) ultimately obtained a satisfactory me- 
chanical result, in two cases after multiple 
operations, but one patient ( L D  44) has 
been left with a mixed fungal and bacterial 
pyelonephritis, the only persistent urinary 
tract infection in the entire series of chronic 
survivors. 
Degree of Rehabilitation. Whether or 
not the chronic survivors have returned to 
their previous social and vocational envi- 
ronment has been dependent largely upon 
the residual disability from pre-existing pe- 
ripheral neuropathy or hypertensive retinal 
disease. Several of the patients with pe- 
ripheral neuritis and marked paresis of 
their lower extremities still have incom- 
plete motor control and one of these (LD 
55)  requires double cane support for am- 
bulation after more than 1 year of normal 
renal function. Although many features of 
the retinopathy proved to be reversible, 
several of the patients have been left with 
serious visual disability.la 
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FIG. 6. Effect of late homograft rejection upon LD 47. The patient and his sibling donor were both 
A+ blood type. Deterioration O F  homograft function followed partial withdrawal of steroids and was not 
completely reversed after resumption of higher doses of prednisone and local homograft irradiation. 
Thymectomy was performed after the onset of the delayed rejection without demonstrable effect. Note 
the inverse relation of the lymphocyte fraction of the peripheral white cell count to the daily steroid dose. 
Most of the late morbidity of immuno- 
suppressive therapy has resulted from 
chronic steroid administration. Four pa- 
tients ( L D  22, 45, 50, 51) have had patho- 
logic fractures of their femoral heads,58 
secondary to osteoporosis. Gastrointestinal 
bleeding, a frequent early c~mpl i ca t ion ,~~  
has not been observed after 1 year. Two 
patients ( L D  40, 54) have formed lens 
cataracts, requiring ocular surgery in one. 
One patient died of septicemia with 
leukopenia; the only other late complica- 
tion which may have been attributable to 
chronic use of azathioprine was liver in- 
jury. Whether the "hepatiitis" alluded to 
earlier in three cases was a drug-induced 
injury or was of viral etiology cannot be 
stated with certainty. Other infectious 
problems have been minimal in those pa- 
tients who lived beyond 1 year. 
All but one of the living patients have 
returned either to school or to a former 
occupa~tion or have been re-educated to 
some other form of gainful employment. 
Chronic Homograft Function. All of 
the living patients have adequate renal 
function (Table 1). The highest BUN (LD 
47) is 70 mg./100 ml.; none of the adults 
have a CCr below 50 ml./min. For the en- 
tire group, the mean BUN in April, 1965 
was 22.5 mg./100 ml. and the mean creati- 
nine clearance was 83.6 ml./min. Five of 
the living patients have proteinuria. The 
greatest loss is in a patient ( L D  1) who 
has excreted 1.5 to 2 Gm. protein per day 
for more than 2 years. 
During the early months after transplan- 
tation, varying degrees of hypertension are 
usually presen~t ,~~ frequently requiring ag- 
gressive treatment with antihypertensive 
agents. With the passage of time and the 
lowering of steroid doses, this problem has 
dirninished in most cases. The average sit- 
ting blood pressures for April 1965 are 
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FIG. 7 .  Late rejection in LD 12 which followed discontinuance of steroids; this was reversed after 
resuntption of steroids, local homograft irradiation and administration of intravenous actinomycin C. 
The prednisone dose has subsequently been dropped to 15 mg./day. Although the patient is in good 
health, his clearance of creatinine, inulin and PAH is somewhat reduced (Table 10) and the pathologic 
changes in his 21-month homograft biopsy are marked (Fig. 8). He is slightly hypertensive. 
shon~n in Table 1 for each patient, and it 
is indicated whether or not any antihy- 
pertensive drugs ( chlorothiazide, hydrala- 
zine, reserpine or methyl DOPA) are be- 
ing used. Renal arteriograms were obtained 
in two cases. One patient (Fig. 1, left) who 
had hypertension had diffuse narrowing of 
intrarend vessels contrasted to a normal 
vascular pattern (Fig. 1, right) in the other 
who was normotensive. 
Additional Function Studies ( DAO ) . 
Seven and five patients received homo- 
grafts from related (Table 10) and unre- 
lated (Table 11) donors, respectively. Al- 
though duration of survival in the related 
series (23.8 months) exceeded that of the 
unrelated group (16.1 months) at the time 
of study, both the glomerular filtration rate 
(inulin clearance) and effective renal 
plasma flow (para-aminohippurate clear- 
ance) were greater in the former ( p  < 0.01, 
p < 0.1). The ability to concentrate or 
dilute urine and to eliminate a water-load 
was also better preserved in the related 
homografts (Table 10, 11). 
Individual patients in both groups had 
inulin and PAH clearances which were 
more than half the adult normal, suggest- 
ing that homograft function can increase- 
similar to the normal remaining kidney 
after ordinary nephrectomy. I t  is interest- 
ing that the filtration fraction was some- 
what high in most cases even in those pa- 
tients (LD 2, 6 )  with completely or nearly 
normal 2-year biopsies (Table 10). 
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FIG. 8. Biopsy of renal homograft 1 year, 10 months after transplantation (LD 12). The lumen of a 
small interlobular artery is narrowed by fibrous thickening of the intima. There is some focal thickening 
of the capillary basement membranes in the glomerulus and a few adhesions between tuft and capsule. 
This patient's clinical course is depicted in Fig. 7 .  Carnoy fixation. Elastic counterstained with hema- 
toxylin and van Gieson. ( X 300.) 
Pathology of Renal Homografts After 1 
Year (KAP) 
One renal homograft (LII 2 )  was abso- 
lutely normal; another (LCD 6)  showed 
only a little scarring in the superficial cor- 
tex just beneath the capsule but was else- 
where normal. The remaining seven trans- 
plants all showed appreciable pathologic 
changes. 
Vascular Changes. Interlobular Arteries. 
In  4 of the biopsies from living patients 
( L D  1, 12, 13, 15) and in the homograft 
removed at  autopsy ( L D  23) intimal thick- 
ening was present in the interlobular ar- 
teries, often accompanied by rupture of 
the internal elastic lamina (Fig. 8).  This 
change did not affect all the vessels and 
was often focal wibthin an individual artery. 
The thickening was caused by a layer of 
fine collagen fibrils Iying between the in- 
ternal elastic lamina and the endothelium 
(Fig. 9 ) .  The elastic layer was wider than 
normal and the individual elastic fibers 
were fragmented, separated and arranged 
in an irregular fashion. Hyaline material, 
with a fine granular structure, formed ir- 
regular patches both in this layer and in 
the intimal collagen. The endothelial lin- 
ing was intact, but its cells were swollen 
and contained many vacuoles and a few 
dense bodies. In some small interlobular 
arteries the lumen was almost occluded. 
The medial muscle cells were compressed 
and granular hyaline material was present 
between them. In the biopsies small inter- 
lobular arteries were the largest vessels 
sampled, but in the one autopsy specimen 
similar intimal thickening and elastic dam- 
age extended into the arcuate and inter- 
lobar arteries. 
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FIG. 9. Biopsy of renal homograft 2 years after transplantation ( L D  1). Internal elastic lamina ( e )  
of a small interlobular artery branch is fragmented and infiltrated with hyaline material. Intima is thick- 
ened by fine collagen fibrils ( c ) .  Endothelium (arrows) is intact but cells are swollen and contain 
vacuoles and electron dense bodies. Renal angiogram in this patient after 2 years was essentially normal 
(Fig. 1 right). Electronmicrograph. Phosphotungstic acid. ( X  5,000.) 
Atfercilt Arterioles. Homogeneous "hya- tion of the interstitium, pyroninophilic cells 
line" material, staining pale pink with were usually found marginating in the lo- 
eosin, \\-as present in the arteriolar walls cal peritubular capillaries. 
of six of nine homografts examined (Fig. Cellular Infiltration. Three transplants 
10) .  Five of these were the cases with in- showed no cellular infiltration ( L D  2, 3, 
terlobular artery changes; the sixth was 6 )  and one other contained only a very 
I,D 13. The "hyaline," composed of com- few cells ( L D  15) .  In the remaining five 
pactly arranged granules measuring about cases there were focal, dense collections of 
200 angstroms in diameter, lay beneath the infiltrating mononuclears (Fig. 13) which 
enclothelium between the basement mem- were most frequent in LD 13 and 23. Be- 
branes of the endothelial and the smooth tween 10 to 50 per cent of these cells had 
muscle layers (Fig. 11). In severely af- cytoplasm which stained deep red with 
fected arterioles the whole wall was re- pyronin and in three of the homografts a 
placed by this material (Fig. 12). few were in mitosis. Ultrastructurally some 
Peritt~bular Capillaries. In one transplant of the infiltrates were large lymphoid cells 
(LD 23) there was appreciable loss of with abundant cytoplasm lacking rough 
peritubular capillaries in the fibrotic inter- endoplasmic reticulum but full of RNA in 
stitium, but in the other cases they ap- the form of ribosome roset'tes (Fig. 14, 15). 
peared normal, even when surrounded by Mitochondria were not abundant in these 
collagen. Where there was cellular infiltra- cells, the Golgi apparatus was well de- 
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FIG. 10. Biopsy of renal homograft 1 year, 9 months after transplantation ( L D  15) .  There is hyaline 
material (arrow) in the wall of an afferent arteriole. Focal deposits of similar material are present in the 
glomerular tuft. Clinical course of this patient is shown in Figure 5. H & E (X 300). 
veloped, multivesicular bodies were fre- 
quent and the nucleus was often indented. 
The nurnber of large lymphoid cells varied 
from case to case but seemed to be roughly 
proportional to the number of pyronin- 
positive cells in the conventional sections. 
Other cells in the interstitium were fibro- 
blasts (Fig. 16) and macrophages. The lat- 
ter were characterized by an abundance of 
cytoplasmic vacuoles and the presence of 
mostly smooth endoplasmic reticulum (Fig. 
17). Small lymphocytes, plasma cells and 
neutrophils never composed more than 10 
per cent of the infiltrate and in most of the 
biopsies were far less frequent. In only one 
homograft were eosinophils present, a case 
( L D  14)  in which protracted eosinophilia 
had characterized a strange febrile episode 
which commenced about 20 days after 
transplantation. 
Interstitial Fibrosis. Only one case 
showed a completely normal interstitium 
( L D  2 ) .  There was slight fibrosis in the 
superficial subcapsular cortex of three cases. 
More generally distributed fibrosis was 
present in the other five homografts (Fig. 
16) .  It  was most marked in LD 13 and 23. 
Glomerular Changes. Periglomerular 
fibrosis, partial tuft fibrosis and occasional 
complete fibrotic obliteration of the whole 
glomerulus occurred in those kidneys with 
vascular narrowing. In four of the trans- 
plants ( L D  1, 3, 12, 15) there were focal 
deposits of finely granular hyaline mate- 
rial on the glomerular capillary basement 
membranes and between the tuft endo- 
FIG. 12. Biops of renal homograft 2 years after transplantation ( L D  1). Wall of a small arteriole 
has been replacedi largely by granular hyaline material (hy) .  The endothelial cells (end)  have swollen, 
vacuolated cytoplasm. Electronmicrograph. Phosphotungstic acid ( X 3,510). 
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FIG. 11. Biopsy of renal homograft 1 year, 9 months after transplantation (LD 15). Granular hyaline 
nlaterial ( h y )  is deposited between the endothelium and the smooth muscle ( S M )  in the wall of an ar- 
teriole. The patient does not have hypertension. Ele-tl.o~~l~~icropraph. Phosphotungstic acid ( x  16,800). 
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FIG. 13. Focus of dense cellular infiltration adjacent to a glomerulus. Two-year biopsy on LD 1. Clinical 
course is shown in Fig. 3. H & E ( X 680). 
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FIG. 15. Detail of a lymphoid cell infiltrating the renal homograft from Patient LD 1 two years after 
transplantation. The cytoplasm is densely packed with tiny rosettes, each composed of 4-6 ribosomes. 
Electronmicrograph. Lead ( X 21,000). 
tllelial cells (Fig. 8, 18). These deposits 
v7ere 0111y severe in two of the cases ( L D  
1, 3 ) .  -1 few of the glomerular epithelial 
foot processes were fused in these cases 
and in LD 1 there was also hyperplasia of 
the endothelial cells. 
Hyperplasia of the Juxtaglomerular 
Apparatus. Some enlargement of the juxta- 
glomerular body was present in six of nine 
homografts (Fig. 19). This was very strik- 
ing in LD 3 and 15-the macula densa was 
pron~inent, vacuolated cells were present in 
the afferent arteriolar wall and the lacis 
cells \\-ere greatly increased in number. 
Elcess granularity was not a feature of this 
hyperplasia. 
Tubular Atrophy. Focal tubular atrophy 
was present in all those cases with vascular 
lesions. It  was most severe in L D  23. In 
the latter case recent tubular damage, bile 
pigment casts and calcification of a few of 
the distal tubular cells were allso present 
as a result of this patient's terminal illness. 
Histopathologic Correlations. With 
function. The two kidneys which were his- 
tologically unaltered at about 2 years had 
completely normal function. Conversely, 
the two homografts which had the most 
severe disruption of general architecture 
in the late biopsy ( L D  12, 13) had the 
lowest clearances of creatinine, inulin or 
PAH; the patient who died after 13% 
months ( L D  23), who was found at au- 
topsy to have pronounced renal damage, 
also had moderate depression of the CCr. 
More precise correlations between specific 
FIG. 14. Ultrastructure of two lymphoid cells infiltrating a renal homograft (Patient LD 1) 2 years 
after transplantation. Each has a prominent nucleolus ( N )  and Golgi body ( g ) .  Cytoplasm is full of 
polyribosomes but lacks rough endoplasmic reticulum (see Fig. 17 ) . Electronmicrograph. Lead 
( X 9,550). 
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FIG. 16. Greatly increased number of collagen fibrils in the interstitiurn of a renal homograft 2 years 
after transplantation (LD 1). A fibroblast ( F )  and a lymphoid cell ( L )  lie embedded in the fibrous 
tissue. Electronmicrograph. Phosphotungstic acid ( X 8,000). 
pathologic changes and function were 
often not found in individual cases. 
For example, only two of four patients 
with glomerular basement membrane ab- 
normalities had proteinuria, and in one of 
these (LD 3 )  the quantities were of doubt- 
ful significance (15 to 400 mg./day). Simi- 
larly, vascular damage at the interlobular 
artery level was not incompatible with 
good function; the four patients with such 
lesions had a mean CCr of 103 ml./min. 
compared to 115 ml./min. in the four with 
normal vessels. Likewise, cellular infiltra- 
tion was pronounced in sorne of the kid- 
neys which had the best function (LD 1, 
14). 
With Late Rejection. Homograft tissue 
was available from three patients who suf- 
fered a late rejection 223 to 300 days after 
transplantation; all three had interlobular 
artery lesions and prominent cellular in- 
filtration. In six other cases without late re- 
jection, two homografts had vascular le- 
sions and four did not; four of these six 
homografts were almost or completely free 
of invading cells. 
With Blood Pressure. Three of the six 
renal homografts which showed lesions in 
the arteries or arterioles at biopsy or au- 
topsy came from patients who late in their 
clinical course developed an elevated di- 
astolic blood pressure; the three patients 
without such histologic changes were all 
normotensive. The presence of juxtaglom- 
erular hyperplasia in the graft did not cor- 
relate either with vascular lesions in the 
graft or hypertension in the patient. The 
fact that these enlarged juxtaglomerular 
bodies did not show excess granularity is 
probably significant. 
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FIG. 17. Xlacrophage lying in interstitium adjacent to the endothelial lining (end)  of a peritubular 
capillary in a renal homograft 2 years after transplantation (LD I ) .  The macrophage has a prominent 
nucleolus ( N ) ;  cytoplasm is full of vacuoles and contains endoplasmic reticulum. Electronmicrograph. 
Lead ( x 10,970). 
Antigen Analysis (PT and DLV) 
A summary of the cytotoxicity reactions 
between each of the long surviving patients 
and their donors is given in Table 12. Un- 
fortunately, not all lymphocyte specimens 
could be examined with a full antibody 
panel due to the periodic unavailability of 
several of the antisera, thereby somewhat 
reducing the accuracy of cross-comparison 
from case to case. This necessary variation 
in testing was partially corrected in each 
instance by dividing [total units mismatch/ 
total weight of units tested], a calculation 
which indicates for each pair the ratio of 
actual mismatch units to the maximal num- 
ber of mismatch units which could have 
been detected with that particular panel in 
the event of total incompatibility. These re- 
sults, which are expressed as percentages 
in the right column, were used for two 
lines of retrospective inquiry. 
Distribution Curve of Mismatches. The 
attainment of long-term homograft func- 
tion in such cases implies that a reason- 
ably satisfactory degree of histocompati- 
bility had been achieved fortuitously, with 
the assumption that the less fortunate pa- 
tients with a poor tissue match would not 
be represented in this residual group. If 
the method of antigen analysis employed 
were capable of detecting histocompatibil- 
ity, the test should be able to demonstrate 
that the surviving patients and their donors 
were in fact more satisfactorily matched 
than would have been expected by chance. 
To test this hypothesis, the antigenic mis- 
matches of the donor-recipient pairs were 
compared to those which were obtained 
from control studies of a random popula- 
tion sample.66 The most important data are 
those from the five living patients in whom 
homografts from nonrelated donors were 
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FIG. 18. Biopsy of renal hoinograft 2 years after transplantation (LD 3).  Part of glomerulus showing 
granular hyaline material ( coarse arrows ) deposited on the glomerular capillary basement membrane and 
between the damaged endothelial cells. There is fusion (fine arrow) of some epithelial ( e p )  foot 
processes. Electronmicrograph. Phosphotungstic acid ( x 21,700). 
employed; the results from these cases in 
comparison to those expected from random 
population matching between nonrelatives 
are summarized in Figure 20. In all five 
instances, the incidence of mismatches of 
those possible was 14.4 per cent or less. 
Thus the surviving recipients were clus- 
tered in the favorable half of a random 
distribution curve of antigenic compatibil- 
ity (Fig. 20). None fell into the unfavor- 
able portion. 
A similar statistical study of the patients 
who had homografts from related donors 
suggests that fortuitous antigen matching 
may have been a determinant of success or 
failure in this group as well, although the 
variability of findings was much greatereGG 
Correlation of Antigenic Compatibility 
with Clinical Course. If the discriminatory 
ability of the test were highly sensitive, it 
should also be possible with antigen analy- 
sis to predict which of the surviving pa- 
tients had the most satisfactory clinical 
course to date. Such an attempt at correla- 
tion proved to be difficult for a number of 
reasons. First, it is known from studies by 
Kirkpatrick, Wilson and Talmage 32 that 
the attenuation of immunologic reactivity 
which accompanies uremia l1 is extremely 
variable and that the degree of consequent 
preoperative immunologic impairment is 
an important factor in determining the 
magnitude and timing of early rejection; 
such variations, which could profoundly 
influence the clinical course, are not de- 
tected with antigen studies. Second, clini- 
cal ranking of the survivors on the basis of 
current renal function was not generally 
useful since most of these patients have 
normal BUN'S and good or exceIlent creati- 
nine clearances. Third, the immunosup- 
pression in different cases was often not 
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FIG. 19. Hyperplastic juxtaglomemlar body (arrow) in a renal homograft 1 year, 9 months after 
transplantation ( L D  15). There are also focal deposits of hyaline material in the glomerular tuft. Periodic 
acid Schiff ( x 300). 
comparable, the variations being princi- 600-  
pally in the amount, timing and duration 
of steroid therapy. Finally, it frequently 
5 0 0 -  proved impossible to say that one patient 
had a better course than any one of a half 
dozen or more others. : 400- 
It ~ 7 a s  finally decided to rate each case 
a clinically as "superior," "satisfactory," or 300- 
"less than satisfactory." The "superior" 11 LL 
0 
patients, all of whom received kidneys from 
related donors, presented few management 200- 
problems after the early postoperative con- 5 
valescence. None had a late rejection. Two 100- ( L D  3, 14) never required steroid therapy 
at any time; in the other 11, prednisone 
was either ultimately discontinued or re- o 
duced to 7.5 mg./day or less. Four pa- TOTAL PER CENT MISMATCH 
tients ( L D  30, 41, 47, 48) were judged 
FIG. 20. Frequency distribution of human an- 
"less than satisfactory," primarily because tigenic nlismatches in a random population of 65 
large prednisone doses per basis individuals, each of whom was matched against 
all the others; approximately 4,200 donor-recipient 
were necessary long after operation to Pre- combinations were possible. See text for details. 
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vent late deterioration of renal function; Thymectomy 
all four have residual functional damage 
to the homograft from late rejection. The 
rest of the patients, 21 in all, who were 
termed "satisfactory" are receiving 7.5 to 
15 mg. prednisone/day. 
The compatibility rating in the 36 sur- 
viving cases is shown in Table 12 for both 
the related and unrelated pairs, in the or- 
der of completeness of the antigen match. 
In the related group the correlation of 
these precise numeric rankings with the 
less detailed clinical ones described above 
was not good in a number of individual in- 
stances. For example, tlie patient with the 
poorest antigen match (LI) 53) has never 
had an overt rejection, is not being treated 
with lieavy immunosuppression and has a 
"satisfactory" result after almost 16 months. 
Tlie same situation pertains to five of the 
next six poorest matches. Conversely, two 
of the "less than satisfactory" results were 
in patients who had relatively well-matched 
donors ( L D  47, 48). With nonrelated pairs, 
there was no evident correlation between 
the clinical result and the results of the 
immunologic study. 
Nevertheless, there was a heavy concen- 
tration of the patients with clinically "su- 
perior" results near the top of the com- 
patibility scale in the related series. All 11 
of these patients were from the top 18 
matches; none had an antigenic mismatch 
greater than 10.1 per cent (Table 12). 
These results indicate that chronic homo- 
graft function can be obtained despite con- 
siderable donor-recipient incompatibility of 
the antigenic systems being studied, but 
they also suggest that the chance of achiev- 
ing an outstanding clinical result is in- 
creased by the presence of a close match 
of these lymphocyte antigens. 
Correlation of Antigen Compatibility 
with Pathologic Findings (KAP). A clear 
correlation did not exist between the de- 
gree of donor and recipient antigen incom- 
patibility and the extent of late histologic 
damage. 
In eight of the first cases, thymectomy 
was performed 14 to 85 days before trans- 
plantation 57, 58, 61 at the suggestion of Dr. 
David W. Talmage. Four patients died 
early after operation from causes other 
than rejection.58 The other four ( L D  1, 2, 
3, 6 )  are still living more than 2 years 
later. Their uniformly smooth late con- 
valescence has prompted speculation that 
the adjuvant procedure may have been of 
long-term benefit.58 
The value, if any, of thymic excision in 
human homotransplantation cannot yet be 
proved. Nevertheless, it seems appropriate 
to consider the present evidence on this 
important point. The following is a further 
analysis of the original four cases with pre- 
transplant thymectomy and an account of 
nine additional patients in whom thymec- 
tomy was carried out long after homotrans- 
plantation. 
Histologic Features of the Thymus 
Glands Removed before Transplation 
(KAP). Three of the thymuses were from 
patients aged 12 to 23 who had not previ- 
ously received corticosteroids ( L D  1, 3, 
6) ;  all three had glomerulonepliritis. The 
weight of the gland, 17 Gm., was recorded 
only for the oldest patient. In each case 
the thymus contained abundant cellular 
tissue. The cortex was well preserved and 
packed with small lymphocytes. In two of 
the glands the medulla contained a few 
germinal centers ( Fig. 21 ), each consisting 
of a central collection of large cells with 
pale nuclei surrounded by a rim of small 
lymphocytes; these two thymuses also con- 
tained many small groups of plasma cells. 
The abnormal presence of the germinal 
centers is of great interest inasmuch as 
several workers, particularly Burnet and 
Mackay, recently have stressed the signifi- 
cance of such structures which have been 
described in the thymus of patients with 
rheumatoid ar thr i t i~ ,~  systemic lupus ery- 
t h e m a t o ~ u s , ' ~ ~ ~  myasthenia g r a ~ i s , ~  thyro- 
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Fic. 2 l .  Thymus removed before homotransplantation from Patient LD 3; the renal disease was 
chronic glomerulonephritis. There is a lymphoid follicle with germinal center in the medulla. H & E 
{ X 1.30). 
tosicosis and Hashimoto's d isea~e .?~  Our 
patients were suffering from chronic glom- 
erulonephritis and, as far as we are aware, 
this is the first time that such an associa- 
tion of thymic and renal changes had been 
recorded. 
The fourth thymus, from a patient (LD 
2 )  aged 28 years who for the 2 months 
prior to thymectomy had received cortico- 
steroids, was atrophic microscopically and 
lacked recognizable cortex. No germinal 
centers were present in this specimen. All 
four thymuses contained more Hassal's cor- 
puscles than normal in the medullary tissue. 
In two of the glands some of these cor- 
puscles \\?ere cystic. 
Clinical Correlations with Pretrans- 
plant Thymectomy. One of the surviving 
four patients (LD 3 )  with pretransplant 
thymectomy has never had homograft de- 
terioration and has not received prednisone. 
The other three had moderate or severe 
early rejection (Fig. 2-4) which was re- 
versed after prednisone and actinomycin C 
were administered. All four patients have 
had essentially unvarying renal function 
during their entire late course. None has 
received any steroid therapy from the sixth 
to the tenth postoperative month onward. 
Each was classified as a "superior" result. 
The other 33 chronic survivors in whom 
pretransplant thymectomy was not per- 
formed also included seven patients who 
were considered to have a "superior" re- 
sult. All have either normal or excellent 
renal function; one has never received ster- 
oids, two others have had steroids discon- 
tinued without harmful effect and four are 
receiving 2.5 to 7.5 mg. prednisone per 
day. Such cases prove that stable chronic 
homograft function is not necessarily de- 
pendent upon steroid therapy even when 
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thymectomy has not been performed. Nev- 
ertheless, a substantial fraction of the 33 
patients who did not have pretransplant 
thymectomy have been demonstrated to re- 
quire chronic administration of prednisone, 
since its complete or partial withdrawal 
has preceded late rejection in nine of these 
patients. As will be pointed out below, this 
late steroid dependence ]nay be due to 
factors other than the presence of the 
thymus. 
Pretransplant Thymectomy and the 
White Blood Cell Count. The average 
monthly white cell count and percentage 
of lymphocytes in the four patients with 
pretransplant thymectomy are shown for 
the first postoperative year in Figure 22. 
The total count remained relatively stable. 
The contribution of lymphocytes to the to- 
tal count progressively increased after the 
first several months, at a tiine when the av- 
of thymectomy and step- 
oid dose to peripheral 
lymphocyte fraction in 
3 distinct groups of pa- 
tients. (Lower) Mean 
values in 4 patients who 
had thymectomy prior 
to homotransplantation. 
Vertical bars represent 
standard error ( SE ) . Note 
progressive lymphocytosis 
in postoperative period 
as average steroid dose 
was decreased. None of 
the patients developed 
late rejection. ( Middle) 
Twenty-five patient? who 
did not have pretraris- 
plant thymectomy and 
who did not have a late 
rejection during the first 
year. SE values in the 
lymphocyte fraction were 
too small to depict. Note 
rise in lymphocyte com- 
ponent as steroid doses 
were decreased. ( Upper) 
Six patients who did not 
have pretransplant thy- 
mectomy and who cle- 
veloped delayed rejection 
between the 7th and 10th 
postoperative months  . 
Note the inverse rela- 
tionship of the lympho- 
cyte fraction to the ster- 
oid dose, both early and 
late after transplantation. 
erage steroid dose was being reduced or 
discontinued. 
Two sets of control data are available 
against which to compare the above find- 
ings. The first was obtained from 25 pa- 
tients who did not have thymectomy but 
who had either a "satisfactory" or "su- 
perior" course during the first year. These 
patients were generally managed in the 
same way as those of the thymectomy 
group although attenuation of the steroid 
dose was somewhat more gradual. The 
white cell counts and lymphocyte fractions 
(Fig. 22) followed the same pattern as that 
observed in the thymectomy group with a 
rising lymphocyte component late in the 
course. 
A second group of six nonthymectomized 
patients were grouped for study since they 
had delayed homograft rejection between 
the seventh and tenth postoperative months. 
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The early management of these cases had 
been similar to that of the above two 
groups, during which the white blood cell 
counts and differentials had been compa- 
rable. \Vith the increased doses of predni- 
sone used to treat the late complication, 
there was an abrupt change with a sec- 
ondar) fall in the lymphocyte percentage 
(Fig. 22). 
These findings suggest: 1) thymectomy 
does not strikingly influence the number 
of circulating lymphocytes in the human 
under the conditions of these experiments; 
2 )  steroid therapy, in contrast, has a 
markecl lymphopenic effect when large 
doses are employed both early and late 
after operation; and 3 )  the level of pe- 
ripheral lymphocytes cannot be related to 
the presence or absence of rejection. 
Histopathologic Correlation (KAP). 
The l-romograft biopsies in the eight most 
cllronic cases provide some basis for histo- 
pathologic correlation since four of these 
patients had pretransplant thymectomy and 
the other four did not. The donors in each 
c'ltegory were a mother and three siblings. 
There \\as a difference between the two 
groups. IVhereas only one of the four pa- 
tients thymectomized before transplanta- 
tion had evidence of vascular lesions in his 
homograft (LD l ) ,  all four patients in the 
nonthynectomized or post-transplant thym- 
ectoniy group developed lesions in either 
the arterioles or the interlobular arteries of 
their grdft. Similarly, cellular infiltration 
\vas only present in one of the transplants 
from the pretransplant thymectomy group 
but involved every transplant in the other 
group. Glomerular basement membrane 
changes occurred with equal frequency in 
the two groups. 
Correlation with Antigen Analysis. 
Earlier, evidence was presented that close 
antigen matching increased the chances of 
obtaining an outstanding clinical result. If 
the patients with pretransplant thymectomy 
were demonstrated to have antigen com- 
patibility comparable to the average pair 
in which this adjuvant operation was not 
carried out, the evidence for the value of 
preliminary thymic excision would be in- 
creased. In actuality, all four of the patients 
who received thymectomy prior to trans- 
plantation had a total unit mismatch of 6.9 
per cent or less, placing them within the 
first ten most compatible donor-recipient 
pairs. This finding makes it impossible to 
exclude the possibility that these favored 
patients had such an excellent long-term 
result primarily as the consequence of a 
high degree of donor-recipient histocom- 
patibility rather than because pretransplant 
thymectomy had been carried out. 
Thymectomy after Transplantation. 
Nine patients with a complicated late 
course received thymectomy from 8% to 
17 months after homotransplantation in the 
hope that reduction of immunosuppression 
would thereby be facilitated. Five of the 
patients had developed late rejection, two 
had steroid-induced cataracts, one had a 
ureterovesical stricture requiring extensive 
reparative operation and one had become 
jaundiced. There is as yet no reason to be- 
lieve that the subsequent course was influ- 
enced by the operation. All but one of the 
patients had been on a slowly diminishing 
dose of prednisone for several months, a 
drug withdrawal which was continued after- 
wards. Late rejection or further deteriora- 
tion of renal function has not occurred in 
this group but it is possible that the same 
result would have been obtained without 
superimposition of the surgical procedure. 
The lymphocyte fraction of the white count 
was not decreased by thymectomy. Instead, 
the per cent of peripheral lymphocytes 
actually increased after removal of the 
thymus, a finding probably due to the fur- 
ther reduction of prednisone after the late 
operation. 
The findings in these thymuses were of 
interest in view of the facts that all of the 
patients had chronically functioning homo- 
grafs and had been on steroid therapy for 
many months. The gross morphology of all 
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of the glands was easily distinguishable at 
operation; their weights ranged from 4 to 
46 Gnl. Microscopically, all nine glands 
lacked recognizable cortex. Germinal cen- 
ters arid mast cells were not found. Four 
of the thymuses, from patients aged 22 
to 41 years ( L D  54, 15, 47, 30), were 
enlarged (mean weight 29.1 Gm.), but 
microscopically they contained only tiny 
strands of thymic medullary tissue em- 
bedded in a large quantity of relatively 
acellular fibro-fatty tissue. The true thymic 
tissue was composed of loose collections of 
spindle-shaped cells, larger "epithelial" 
cells and a few small lym]?hocytes. Occa- 
sional plasma cells were scattered amongst 
the other elements. Similar atrophic mi- 
croscopic changes were present in two un- 
enlarged thymuses (mean weight 6.3 Gm.) 
removed from patients aged 17 and 21 
years ( L D  50, 40). 
Three small thymuses (mean weight 7 
Gm.) from patients aged 4 to 16 ( L D  13, 
22, 41 ) contained plenty of cellular, thymic 
tissue composed of densely packed lympho- 
cytes and some epithelial cells. Hassal's 
corpuscles, cystic in one case, were abun- 
dant but within the normal range for this 
age group. Plasma cells, scattered through- 
out the thymic tissue, were slightly more 
frequent than in the other six thymuses. 
Discussion 
Although greatly improved early results 
after human renal homotransplantation 
have been reported from several centers,15. 
23, 29, 45, 46 the procedure is still of Iimited 
utility for two fundamental reasons. First, 
the explanation for success or failure in in- 
dividual cases is often not evident, a fact 
which has made it difficult to either evalu- 
ate the effect of variations in immunosup- 
pressive therapy or extrapolate accurately 
from past experience for improvement of 
donor selection in future trials. Second, the 
ultimate prognosis of those patients who 
have already reached a c'hronic phase of 
recovery is not known. In the present study 
an attempt has been made to acquire data 
which bears on both of these general ques- 
tions. 
From the experience to date it seems cer- 
tain that the most important single deter- 
minant of the outcome is the degree of 
histocompatibility which exists between 
the donor and recipient, a concept previ- 
ously well established with animal experi- 
ments employing genetically controlled 
 strain^.^^,^^ The favorable outlook with 
homografts from blood relatives is expli- 
cable on this basis since the statistical prob- 
ability of accidentally obtaining a satisfac- 
tory histocompatibility is good; with non- 
related donors this possibility is greatly 
reduced.53 In both groups a spectrum of 
donor acceptability apparently exists, mak- 
ing it imperative that the several technics 
for assessing donor-recipient compatibility 
in advance of operation 26 be perfected and 
given a clinical trial. 
The data on antigen analysis in the pres- 
ent study provide hope that the lymphocyte 
cytotoxicity determination may be of some 
value for this purpose. The patients still 
living had a better antigen match with 
their donors than would have been ex- 
pected by chance; the corollary deduction 
is that most of those in this series with 
highly unfavorable matches are already 
dead. Moreover, the really superior clini- 
cal results tended to be in those patients 
whose lymphocytes lacked the fewest anti- 
gens possessed by the donor. 
Despite these encouraging notations, the 
detailed correlation between the retrospec- 
tive matching and the clinical results in 
the chronic survivors was irregular and in- 
complete. Thus, the method in its present 
form has several distinct disadvantages 
which seem due principally to the fact that 
antigens of unknown histocompatibility 
significance are being tested with poly- 
valent antisera and to the likelihood that 
antigenic screening is incomplete. An 
analysis of the deficiencies and advantages 
of the technic and the means by which the 
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information already obtained can be used 
to improve its performance are considered 
in detail in a separate p u b l i ~ a t i o n . ~ ~ ~  67 In 
addition, prospective typing studies have 
been undertaken in fresh cases of renal 
homotransplantation in order to determine 
if an increased rate of success can actually 
be attained by attention to matching. 
Imperfect though antigen typing is at 
the present stage of development, the re- 
sults from these studies are important in 
considering the possible influence of thym- 
ectomy upon the long-term results. The 
four patients with pretransplant thymic 
excision who have had excellent sustained 
homograft function also had exceptionally 
complete antigen matches with their do- 
nors. Until matching technics are perfected 
to the degree that histocon~patibility can 
be defined with greater precision, it will 
be difficult in humans to prove decisively 
that thymectomy is of value. Should that 
time come, it will be possible to study se- 
ries with comparable histocompatibility, 
half treated with and half without removal 
of the thymus gland. 
In the meanwhile, there is a growing body 
of evidence from well-controlled experi- 
ments with inbred lower animals that 
thymectomy in adult life can prevent or 
slow restoration of immunologic compe- 
tence after a period of depression. Miller 
and associates 3 8 9  3Qave demonstrated 
in adult mice that total body irradiation 
plus thymectomy results in much longer 
potentiation of skin homograft survival 
than irradiation alone. The protocol in 
some of these studies 38 was almost identi- 
cal to that employed for the early treat- 
ment of Patient LD 1 in the present re- 
port. In other experiments lo, 3 V t  was 
noted that reinfusion of isologous splenic 
cells prevented the protracted immuno- 
logic depression after th~mectomy and ir- 
radiation, a point deserving special men- 
tion since splenectomy has been carried out 
routinely in our human series. Similar ob- 
servations concerning the role of the adult 
mouse thymus in recovery of depressed im- 
munologic capacity were recently reported 
by Monaco, Wood, and Russell,40 using a 
heterologous antilymphocyte serum as the 
immunosuppressive agent and skin homo- 
transplantation as a test system. Finally, 
the studies of Claman and Talmage8 and 
Taylor 63 suggest that prior sensitization to 
an antigen does not necessarily preclude 
the same general effect of thymic excision 
ill adult life, a finding which might apply 
in those human cases in which thymectomy 
was performed long after homotransplanta- 
tion. In their investigations, mice were ren- 
dered tolerant to bovine gamma globulin 
or bovine serum albumin by intermittent 
injection from birth. Thymectomy in adult 
life materially slowed recovery from the 
tolerant state. 
The above remarks indicate the direc- 
tion of basic research being followed in a 
number of laboratories, involving the de- 
velopment of methods for detection of his- 
tocompatibility. The consequences of these 
efforts should be a reduction in future 
mortality and the establishment of criteria 
for the clinical evaluation of drugs, bio- 
logic methods of preventing rejection and 
adjuvant procedures such as thymectomy 
or splenectomy. An immediate practical 
question remains; what is the long-term 
prognosis of that growing body of chronic 
survivors treated at a less sophisticated ear- 
lier time? 
Barnes1 recently has attempted a sta- 
tistical answer to this question with sur- 
vival data obtained from the world Reg- 
istry in Human Kidney Transplantation of 
September 15, 1964.46 His study was based 
principally upon the death rate in the over- 
all group during the first 1 to 2 years. The 
fact that almost all the mortality was early 
rather than late after operation led him to 
predict that few additional deaths would 
occur during the first 5 years and that 
sibling homografts might prove to be as 
durable as, or even superior to, those from 
identical twins. As he pointed out, the 
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greatest weakness of the highly optimistic probable from the earlier investigations, 
predictions is the very small number of pa- but that there is also a deposition of finely 
tients who actually had lived more than 2 granular material among the fragmented 
years at the time of these calculations. elastic lamina and between the medial 
Examinations of this problem with muscle fibers. Similar "hyaline" is also 
broader criteria than death or current sur- found beneath the endothelium in the af- 
viva1 may be useful, especially since all 64 ferent arterioles and glomerular capillaries 
patients in the present study had been sub- of several of these homografts. The fine 
mitted to the Registry and were included structure of this substance is not particu- 
in Barnes's statistics. The 37 recipients who larly distinctive and it resembles that found 
were still alive at that tiine were already on the glomerular capillary basement mem- 
5% to 22 months postoperative and there- branes in both human41 and experimental 
fore contributed a sizable fraction to the nephritis.14 Subendothelial and intercellu- 
total of the chronic group which occupied lar deposits in renal transplants, together 
his attention. The fact that only one of with proliferation of the glomerular capil- 
these 37 patients has died in the subse- lary endothelial cells, have been illustrated 
quent 8 months tends to support Barnes's beautifully by Harrtburger et ~ 1 . ~ ~  They 
general conclusion that the late attrition describe a patient, still alive, in whom 
after renal homotransplanitation will be ex- these lesions developed in the renal homo- 
tremely gradual for some time to come. graft about 6 months after transplanta- 
Nevertheless, several considerations warn tion. A slow spontaneous reversal of the 
against full acceptance of these conch- clinical manifestations followed and 2 years 
sions. The acute late rejection in nine pa- after operation proteinuria ceased. In a 
tients is clear evidence of continuing host second case the same authors were able to 
reaction against the homosraft. 111 many of show fixation on the glomerular tuft of 
the others the same process may be occur- fl~orescent antibody to human globulin. 
ring at a subclinical level; the reduced, al- Two further cases showed smaller glomeru- 
though still adequate, function of the non- lar deposits. These changes may represent 
related homografts after 12 to 19 months chronic deposition of antibody directed 
is probably a manifestation of such a proc- against the homograft, but in our cases we 
ess. In many others, stable homograft per- have no evidence whether this material is 
formance has been possillle only by con- 7s gamma globulin, let alone specific anti- 
tinuation of potentially toxic doses of body. 
steroids. A further indication that some at least 
Study of the the homografts of these homografts are still under active 
after 1 to 2 years also engenders concern 
attack is the presence in the cellular in- 
that even kidneys with completely normal filtrate of a variable proportion ( the high- function may be the site of active trans- 
plant disease. Five of these nine homo- est was 40%) of characteristic lymphoid 
grafts showed obliterative lesions in the with abundant of 
interlobular arteries, such changes have wmes. These cells were first described by 
often been seen previously in the vessels Galle and Montera 35 in two human renal 
of transplanted kidneys and their possible homografts 70 and 63 days after transplan- 
etiology has been discussed at length else- tation. They found that approximately 40 
where.47 The ultrastructural studies per- per cent of the infiltrating cells were of 
formed on the present cases now show that this lymphoid type. These cells are typi- 
in these vessels not only is the intima thick- cally found in the acute stage of renal 
ened by fine collagen fibrils, which seemed homograft rejection in untreated animals,48 
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but similar cells infiltrate rejecting skin 
homo graft^.^^ 
Despite its recent more liberal applica- 
tion, workers in the field have repeatedly 
warned of the experimental nature of hu- 
man renal homotransplantation. The time 
has not come for changing this position, 
although it has become possible to predict 
with greater insight the ultimate role of 
this form of treatment in the overall medi- 
cal armamentarium. I t  has become increas- 
ingly clear that many patients with termi- 
nal uremia can be benefited materially, 
with relatively complete social and voca- 
tional rehabilitation over considerable pe- 
riods of time. Furthermore, the regularity 
with which this can be achieved, even 
without refinements of histoconlpatibility 
matching, is quite predictable in statistical 
terms. Already a prospective candidate and 
his or her family can b e  given in advance 
an idea of the 1- to 2-year prognosis based 
upon the source of the homograft. In the 
collection of the world results the sibling 
has seemed to b e  the most suitable do- 
although in the present study re- 
cipients of parental kidneys fared better. 
The outlook with homografts from nonre- 
lated sources is poor with random donor 
selection such as that practiced in the past. 
Whether the results in all groups can be 
improved by histocompatibility matching, 
by better immunosuppressive management 
and by adjuvant biologic measures such as 
thymectomy remains to be seen. Conclu- 
sions beyond these appear unwarranted for 
reasons cited earlier, and for the present 
it would seem most reasonable to regard 
lloinotransplantation as an effective, but in- 
completely characterized, form of pallia- 
tive therapy. 
Summary 
Sixty-four patients were treated from 
1354 to 30 months ago with homografts 
from volunteer donors. Thirty-seven of 
these recipients lived 1 year or more; 36 
are still alive with a mean survival of 19 
months. Thirty-one of the 46 who received 
kidneys from blood relatives are still alive 
(67%),  contrasted to only 5 of 18 who had 
unrelated donors (28%) .  In most cases, 
the necessary dose of immunosuppressive 
agents declined with the passage of time. 
Nevertheless, nine patients in whom ster- 
oids were partially or completely with- 
drawn developed a late rejection. 
The function of the homografts after 
13% to 30 months ranged from adequate 
to completely normal. A measurable reduc- 
tion in excretory capacity was present in 
all homografts obtained from nonrelatives 
and in most of the transplants which had 
passed through a clinically reversible late 
rejection. Mild and easily controlled hyper- 
tension was common. All but one of the 
patients is in school or gainfully employed. 
The principal late morbidity from the 
chronic administration of immunosuppres- 
sive agents has been from steroids rather 
than from azathioprine. 
Eight renal homografts were biopsied 
after to 2 years; a ninth transplant was 
examined at autopsy 13$/, months after 
transplantation. Two of the biopsies were 
within normal limits. Six of the other seven 
specimens showed vascular lesions and cel- 
lular infiltration which were often not re- 
flected in depressed function. 
There \yere two forms of vascular change: 
fibrous intimal thickening of the interlobu- 
lar arteries and deposits of finely granular 
"hyaline" material in the afferent arteriolar 
walls. In the glomeruli deposits of similar 
granular material were present on the 
capillary basement membranes and be- 
tween the endothelial cells. The transplant 
examined at autopsy had severe oblitera- 
tive vascular lesions affecting the arcuate 
and interlobar as well as the interlobular 
arteries. Hyperplasia of the juxtaglomeru- 
lar apparatus was present in five of the 
eight biopsied transplants, including one 
which was otherwise normal. Tubular atro- 
phy and interstitial fibrosis were present in 
those cases with vascular narrowing. 
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Up to 40 per cent of the cells infiltrati~lg 
the interstitium were large, of the lym- 
phoid series and characterized by a promi- 
nent Golgi apparatus and cytoplasm packed 
full of polyribosomes. Macrophages and 
fibroblasts were less common. Small lym- 
phocytes and plasma cells were rare. 
White blood cell antigens of the 36 sur- 
viving patients and their donors were 
studied with a lymphocyte cytotoxicity test 
to determine by retrospelctive analysis if 
this method might be helpful in evaluating 
the results as well as in the selection of 
donors for future cases. The correlation of 
the immunologic rating with the clinical 
result was imperfect in individual cases; 
many patients with pooir matches have 
done well and two with good matches have 
had late difficulty. Nevertheless, the pa- 
tients with the best course tended to be 
those with the least degree of antigenic 
inconipatibility with their donors. Further- 
more, the extent of donor-recipient incom- 
patibility in the entire group was less than 
that which would have been predicted by 
indiscriminate pairing. These results sug- 
gest that the antigens being measured may 
have some relation, if only indirect, with 
histocompatibility. 
Evidence is reviewed concerning the in- 
fluence of thymectomy upon the course 
after homotransplanttation in the adult hu- 
man. Four patients who had their thymus 
glands excised before transplantation are 
alive after 2 to 234 years;  he adjuvant pro- 
cedure did not influence the per cent of 
peripheral lymphocytes. L411 four patients 
have excellent and stable renal function. 
None are receiving steroids, and none have 
had any evidence of delayed rejection. The 
ease of late management of these patients 
and the degree of histologic preservation 
of their homografts exceetl that of most of 
the nonthymectomized group. These find- 
ings are difficult to interpret since the de- 
gree of antigenic matching with their do- 
nors was exceptional~ly favorable in all four 
instances. 
Nine additional patients have had thym- 
ectomy long after homotransplantation 
without demonstrable benefit to date. The 
lymphoid components of these glands were 
atrophic but the "epithelial" elements were 
preserved. 
Addendum 
During the more than 3 months since submis- 
sion of the manuscript, there has been no addi- 
tional mortality or loss of homografts. Twenty-four 
of the 36 surviving patients are currently 17 to 24 
months postoperative; the other 12 are now 2 
years or longer. 
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DR. WILHELM BROSIG (Berlin-Charlottenburg, 
Germany): Dr. Starzl's work and results in the 
field of kidney transplantation are outstanding, 
and the best which have been reported. I wish 
to extend my congratulations to him and the other 
American surgeons who have done pioneer work 
in the field of organ transplantation. 
In Germany have been made only reluctant 
attempts in kidney transplantations; stimulated by 
a talk by Dr. Goodwin at the Free University of 
West Berlin in 1959 we started first in experi- 
mental work. 
Since October, 1963, we have performed five 
homotransplantations in man. One patient is living 
over 12 months with good kidney function. All 
others have died, one 8 months after transplanta- 
tion from sepsis; another 4 weeks after trans- 
plantation, also from sepsis; another 6 days from 
a disruption of the transplanted kidney, and the 
fifth one from acute rejection within 5 days. 
Our results are rather poor compared with the 
achievements made in the American clinics. But 
we have made a start, and this was only possi- 
ble by the support and advice of our American 
colleagues. 
DR. DAVID M. HUME (Richmond): I had the 
pleasure of reading Dr. Starzl's manuscript, and 
should like to say that our own results and con- 
clusions are very similar to his. 
We have carried out renal homotransplants in 
40 patients more than a year ago. Of this group, 
21 patients are alive at the present time. Thirty- 
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one of 40 patients had living donors, of which 
27 came from relatives. Nine of the group had 
cadaver kidneys; 53 per cent of the entire group 
are alive after more than one year. There are 
cight patients, all told, who were transplanted 
over two years ago. Five of the eight patients 
(63%) are living at the present time. Six had 
living donors; two had cadaver donors; two had 
second transplants. 
In our own group, no matching was attempted, 
and all the cases, including the cadavers, are 
counted. Twenty of the 21 patients surviving over 
a year have essentially normal kidney function. NO 
patient in the entire series has died after one 
year, although two have chronologically rejected 
their transplants at 15 and 16 months and are 
doing well with retransplants. 
Of these patients receiving transplants in the 
last year over 90% are living at the present time, 
and half of this group had cadaver donors. Sple- 
nectomy was performed in 30 of 60 patients. We no 
longer do splenecton~ies because of the increased 
complication rate in splenectomized patients of in- 
fection and thrombo-embolic phenomena, and be- 
cause we could not demonstrate any immunologic 
benefit from this procedure. We have had no 
late ureter problems of the sort Dr. Starzl has 
seen and ascribed to rejection of the ureter. There 
has been only one significant ureter complication 
in 60 transplants. We have seen some late micro- 
scopic changes which are identical to the ones 
he described here, and we certainly agree with 
him that the kidney has to fight to keep its place 
in the sun. 
We think that perhaps there may be good 
donors and bad donors, rather than donors which 
precisely match their recipients. Some of our stud- 
ies have suggested the possibility that there may 
be a sort of universal donor, whose kidney is 
good for any recipient, while other donors are not 
very good no matter who gets the kidney. 
DR. PAUL S. RUSSELL (Boston): I should like 
to comment upon three points: First, the very 
real importance of donor selection. The basic rules 
of immunogenetics are well substantiated in the 
results of the world experience of more than 500 
kidney transplants. It is quite clear that the more 
closely related the donor is to the recipient, the 
less will be the antigenic barrier between them. 
The method of matching now being developed 
by Dr. Terasaki of UCLA, with whom Dr. Starzl 
has collaborated, is an ingenious improvement 
over Dausset's original work, and appears to be 
quite promising from the retrospective studies so 
far done. 
It  is only one of several different matching 
approaches currently under study, and does not, 
of course, result in knowledge of characterized and 
defined antigens as is now possible with the eryth- 
rocyte groups. It is my guess that full definition 
or typing of the operative antigens provoking 
transplantation immunity will eventually be pos- 
sible. If so, this will be preferable to any of the 
matching methods alone. 
The second point I would like to raise is that 
even after these transplants have been doing well 
for periods of weeks and months, their immuno- 
logic relationship to the host is highly variable. 
In general, there tends to be a low-grade process 
of immunologic destruction in many of the trans- 
plants over a long period of time. This is not 
always the case, however, and here is an example 
of what appears to be just the opposite. 
(Slide) This is a biopsy, taken at 60 days, 
of a kidney transplant to a 35-year-old man with 
terminal glomerulonephritis, who received this 
kidney from an older brother. There is a heavy 
infiltrate, predominantly of mononuclear cells, 
which we thought was a very ominous sign, in- 
deed. Nevertheless, his kidney function continued 
to be nearly normal, and the second biopsy (Slide) 
at 1034 months showed considerable clearing of 
the cellular infiltrate, even though no change in 
his basic program of immunosuppressive treatment 
had been made in the meanwhile. 
(Slide) At a year and a half, the infiltrate had 
reached almost completely. The patient now has 
entirely normal renal function and has been back 
to his full program of work over 2 years after 
operation. 
I will not labor you as to our guesses as to 
the mechanism of this striking improvement, but 
it probably represents a phenomenon of fnnda- 
nlental importance, 
Finally, I should just like to mention that in 
a current series of experiments Dr. Anthony 
Monaco and I have found clear evidence that 
thymectomy in the adult mouse, quite distin- 
guished from the newborn mouse, greatly delays 
the animal's ability to restore its lymphoid tissues 
following injections of the specific antilympho- 
cyte serum. Splenectomy does not have this effect. 
These observations, therefore, suggest that thy- 
mectomy may prove to have a certain place in 
clinical transplantation in the future. 
DR. WILLARD E. GOODWIN (LOS Angeles) : 1 
have had the privilege of reading the manuscript 
and can assure you that for anyone interested in 
the field of kidney transplantation, this represents 
the best synthesis of information and summary of 
results from one group to date. It is truly im- 
pressive. 
Future hopes for transplantation, as Dr. Starzl 
pointed out, are in better matching, better drugs, 
and perhaps some manipulations to change the 
immunologic mechanism. We wish we could get 
Dr. Terasaki to do more of these matching tests 
for us at U.C.L.A.; but often he has been so busy 
working for Dr. Starzl that we could only get 
him to do it once in a while. 
May I show you an example of unexpected 
transplantation of a cancer from donor to recipient, 
along with a renal homograft. The donor died 
of bronchogenic carcinoma with brain metastases. 
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This slide shows the cliriical course of the 
recipient who received the transplanted kidney 
in August 1964. At the time of the transplantation 
there was nothing to suggesi local involvement 
of the transplanted kidney wlth cancer. You see 
that the patient received immuran and prednisone. 
In December, he began to be sick and had a 
swelling in the transplanted kidney. Nonetheless 
renal function remained nearly normal up to the 
time of death. A biopsy of the transplanted kid- 
ney showed nornlal cortex, but in this next slide 
we see cancer growing in the medulla. 
We thought that when immunosuppressive 
drugs were stopped the cancer would die. How- 
ever, it did not work out that way. Things moved 
too rapidly. The transplanted tumor metastasized 
and killed the recipient. This case will be reported 
in detail by my associate, Dr. Donald Martin. 
(J.A.M.A., 192:752, 1965.) 
We are still continuing to use some kidneys 
for transplantation from cadavers. Nonetheless, we 
are very concerned about what they die of. 
In my view, we should not gfve up totally the 
idea of patients with cancer as prospective renal 
donors. We have one very striking success about 
which I told you a year ago. An entirely unrelated 
man received a free kidney from a man who had 
cancer of the ureter, which was treated by nephro- 
ureterectomy in June 1963. The receipient is still 
alive and well. 
One may even speculate that: the very fact 
that the donor HAD a cancer may in some unex- 
plained way account for this uncom;monly good 
result of unrelated renal homotransplantation. 
DR. RALPH STRAFFON (Cleveland): I had an 
opportunity to review the manuscript. As you 
might imagine, securing live donors in a large 
series of patients is always difficult. Dr. Starzl's 
series concerns the use of kitheys from live do- 
nors. We have a fairly large series in which ca- 
daver donors have been the primary source of 
kidney homografts. 
(Slide) This deals with our experience from 
January 1963 until April 15: 1965. During this 
period of time, 40 patients received 47 renal 
transplants from cadaver donors. At the present 
time 23 patients have survived. Twenty-one have 
functioning kidneys, which g~ves an over-all sur- 
vival of about 52%. 
If you look at it from the years, during the 
first year, 1963, our results were not very good, 
perhaps because of the poor selection of donors. 
Since then, results have steadily improved. 
(Slide) It is difficult to obtain kidneys for 
transplantation whether using living or cadaver 
donors. In all cases we have used both kidneys 
of the cadavers for transplantation, doing two 
simultaneous transplantations, which is an added 
advantage. We found from experience that pa- 
tients who died suddenly are the best source of 
donor kidneys in the cadaver group. 
Other hospitals in Cleveland have co-operated 
in supplying cadaver donors. Three kidneys for 
transplantation were brought from other hospitals 
to our hospital. Two of them are successful and 
one is so recent it is too soon to evaluate. 
(Slide) When one is employing cadaver kid- 
neys, one must usually expect a period of acute 
renal failure in the recipient. In our 47 patients, 
only 5 have not required dialysis postoperatively. 
The period of oliguria has ranged from a few days 
to 24 days. 
The logistic problem in cadaver transplants 
prolongs the period of renal ischemia. The ischemic 
period has ranged from 1% hours to 5% hours 
in cadaver transplants in contrast to 20 or 30 min- 
utes when live donors are used. 
(Slide) This shows the duration of survival 
after transplantation with cadaver homografts. The 
survival periods are not so long as Dr. Starzl's 
group with live donors-we have one now that is 
approaching two years. We have three surviving 
more than a year, and eight patients in the 9 to 
12-month category, with functioning kidneys. 
The patients that are alive beyond the 3-month 
period are doing well and their renal function is 
as good as that in our live donors in the same 
category. There are enough encouraging results 
with cadaver transplants to encourage investiga- 
tion in this field. 
DR. RICHARD WILSON (Boston): I can only 
second what Dr. Goodwin had to say about this 
paper. It  is a magnificent exposition of his work 
with these patients. 
I would like to make a couple of comments. 
First of all, the problem at the moment with the 
early postoperative lack of survival is, in part, due 
to acute rejection phenomena-an inability to pre- 
dict which patients are going to be able to go 
on and fall into long-term periods. 
One of the things that we have been trying to 
do to improve the initial results is to add thoracic 
duct fistula and antigen competition to the initial 
treatment of these patients, in an attempt to carry 
some people through this early period. It is still 
too early to say what the results are, but they 
are suggestive that we have not had to place 
patients on therapy for acute rejection within the 
first 3 weeks since we have begun this program. 
Secondly, we have done a series of splenecto- 
mized and nonsplenectomized patients and have 
also given up splenectomy, as Dr. Hume has, be- 
cause we were not able to show any evidence 
that splenectomy provided a better result. 
With regard to the thymectomy in the long- 
term patients, it is interesting that we have two 
patients over 2 years not on steroids. One of them 
received steroids for 4 days only, at about 6 weeks 
after transplant, and then they were stopped. An- 
other one was placed on steroids at about a year 
and a half in an attempt to reverse what we 
thought was beginning difficulty with a late rejec- 
tion. The steroids were stopped because he devel- 
oped GI bleeding, and he has never had them 
since. Both patients have creatinine clearance 
which are normal, and it is, as Dr. Starzl intimated 
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in both his talk and his manuscript, very difficult 
to know what the role of thymectomy in the long- 
term results are, with the lack of definite antigen 
matching. 
Finally, I would like to ask Dr. Starzl a ques- 
tion because we believe that with the therapy 
at the moment still being rather empiric, or quite 
empiric, the most important thing that we can 
do is to diagnose rejection as early a7 possible 
in these patients, and then institute the most effi- 
cient treatment-whatever you think it is-for 
this acute rejection phenomenon, in order to im- 
prove the result and prevent progressive damage 
to the kidney. 
We have been trying to do arteriograms on 
these patients to pick up early rejection. We have 
done a large study with renograms and are con- 
tinuing to do many serial renograms. We are 
doing frequent biopsies, and I would like to 
hear more about his thoughts about the early 
diagnosis of acute rejection. 
MR. ROY CALNE (London, England): Any- 
body who has had the privilege to visit Denver 
recently must have been impressed by the phe- 
nomenal energy that is being devoted by this 
group toward studying the problems of organ 
transplants. 
I think that there are two major contributions 
that this paper provides. First it shows what can 
be achieved with technical excellence and atten- 
tion to the minuitiae of details in clinical care. 
Secondly, the collection and very careful docu- 
mentation of comprehensive data on these cases 
will be of lasting importance. 
Everybody working in this field is worried 
by the ethical problems that transplantation from 
live donors raises, and I think that Dr. Starzl's 
extremely careful approach to the patients has 
provided data which will always be of value to 
future workers in live and cadaver organ trans- 
plantation. 
I would like to comment on the Terasaki test, 
and most other methods that have been used for 
donor typing. They may be relevant to the donor 
and recipient in question, but they do not provide 
definitive tissue groups that can be related from 
one case to another throughout the world in the 
same way as A.B.O. blood groups. I fear that 
even if we do get a perfect method of tissue- 
typing we will be faced with new problems of 
finding a good donor who happens not to want 
to give his kidney. 
With regard to the question of thymectomy. 
We have thymectomized adult dogs and found 
this procedure to be of no value in prolonging 
survival of transplants when combined with the 
standard immunosuppressive therapy. However, 
there are obviously great species differences, and 
as you heard, the adult mouse seems to respond 
well to a thymectomy. 
DR. T. E. STARZL (closing): Since the hour 
is late I will confine my remarks to those specific 
questions which have been raised. First, Dr. Hume 
has already told you that his over-all results in- 
clude not only those patients with living donors 
but those with cadaver homografts as well. Our 
cadaver group, consisting of three unsuccessfully 
treated patients, has not been included in this 
analysis. By confining our attention to those cases 
with living donors the experimental situation was 
largely equivalent throughout the series, allowing 
somewhat clearer conclusions to be drawn. Dr. 
Hume's results and those from the Cleveland Clinic 
have really been magnificent in the cadaver field, 
and their efforts, I am sure, will promote research 
in this area. 
I meant to make clear the fact that we have 
reached no conclusions about the effects of thy- 
mectomy in the human; the results are uninter- 
pretable. The point that I did wish to make was 
that those patients, who received this additional 
procedure and who lived for a long time after 
subsequent transplantation, seemed not to have 
very much late immunologic activity directed 
against their graft. Whether or not thymectomy 
contributed to the benignancy of the late course 
is not known. 
Concerning the early diagnosis of rejection, 
we have been very interested in the worlc done 
by Kountz and Cohn and their associates at Stan- 
ford, concerning the diminution of blood flow 
which seems to precede overt rejection. 
Although it is too early to be certain, it may 
be that importance of early diagnosis of rejection 
may be somewhat lessened with refinements of 
antigen matching technics. Since last fall, Dr. 
Paul Terasaki has been performing prospective 
typing on our new patients, and the vigor of 
rejection in these later cases has seemed to be 
generally less than that observed in the original 
series. In fact, there have been no acute secondary 
anurias since Dr. Terasaki has selected our donors 
for us. 
I think Dr. Terasaki, if he were here, would 
probably make the same remarks about his tech- 
nic, in a self-critical vein, as Dr. Calne already has. 
The weakness of the method is, of course, the 
fact that one is measuring something unknown 
with a polyvalent antiserum, and as Dr. Calne 
has pointed out, it is a little bit like shooting 
buckshot in the air, hoping to strike an unspecified 
target. 
Dr. Terasaki's objective is to use the data from 
these and other human cases to try to distinguish 
which of the antigenic units now being measured 
are related to histocompatibility, so that in the 
long run a practical and simple method of histo- 
compatibility measurement can be evolved. 
